Vanadium-Substituted Polyoxometalates Regulate Prion Protein Fragment 106-126 Misfolding by an Oxidation Strategy.

Prion disorders are a group of lethal infectious neurodegenerative diseases caused by the spontaneous aggregation of misfolded prion proteins (PrPSc). The oxidation of such proteins by chemical reagents can significantly modulate their aggregation behavior. Herein, we exploit a series of vanadium-substituted Keggin-type tungsten and molybdenum POMs (W- and Mo-POMs) as chemical tools to oxidize PrP106-126 (denoted as PrP), an ideal model for studying PrPSc. Due to the band gaps being larger than that of Mo-POMs, W-POMs possess higher structural stability and show stronger binding and oxidation effect on PrP. Additionally, the substitution of W/Mo by vanadium elevates the local electron distribution on the bridged O(26) atom, thereby strengthening the hydrogen bonding of POMs with the histidine site. Most importantly, with the number of substituted vanadium increases, the LUMO energy level of POMs decreases, making it easier to accept electrons from methionine. As a result, PW10V2 displays the strongest oxidation on the methionine residue of PrP, leading to an excellent inhibitory effect on PrP aggregation and a significant attenuation on its neurotoxicity.

[1]  W. Zhang,et al.  Perylene‐Mediated Electron Leakage in Respiratory Chain to Trigger Endogenous ROS Burst for Hypoxic Cancer Chemo‐Immunotherapy , 2022, Advanced science.

[2]  Huile Gao,et al.  Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease Therapy. , 2022, Small.

[3]  Madhuparna Roy,et al.  Second Sphere Interactions in Amyloidogenic Diseases. , 2022, Chemical reviews.

[4]  J. Ren,et al.  Site-directed Chemical Modification of Amyloid by Polyoxometalates for Inhibition of Protein Misfolding and Aggregation. , 2022, Angewandte Chemie.

[5]  S. Hornemann,et al.  A conformational switch controlling the toxicity of the prion protein , 2021, bioRxiv.

[6]  G. Schröder,et al.  Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids. , 2021, Chemical reviews.

[7]  Hua Mei,et al.  Polyoxometalate-Based Metal-Organic Frameworks with Unique High-Nuclearity Water Clusters. , 2020, ACS applied materials & interfaces.

[8]  M. Barreca,et al.  The Compelling Demand for an Effective PrPC-Directed Therapy against Prion Diseases , 2020, ACS medicinal chemistry letters.

[9]  C. Raggi,et al.  Small Molecules with Anti Prion Activity. , 2020, Current medicinal chemistry.

[10]  D. Fu,et al.  Detection of amyloid-beta by Fmoc-KLVFF self-assembled fluorescent nanoparticles for Alzheimer’s disease diagnosis , 2020 .

[11]  X. Qu,et al.  A Biocompatible Second Near-Infrared Nanozyme for Spatiotemporal and Non-Invasive Attenuation of Amyloid Deposition through Scalp and Skull. , 2020, ACS nano.

[12]  Jie Chen,et al.  Cryo-EM structure of an amyloid fibril formed by full-length human prion protein , 2020, Nature Structural & Molecular Biology.

[13]  G. Zhu,et al.  Confining Polyoxometalate Clusters into Porous Aromatic Framework Materials for Catalytic Desulfurization of Dibenzothiophene. , 2020, ACS applied materials & interfaces.

[14]  Tiedong Sun,et al.  Organoplatinum-Substituted Polyoxometalate Inhibits β-amyloid Aggregation for Alzheimer's Therapy. , 2019, Angewandte Chemie.

[15]  L. Shimon,et al.  Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by the Cu(II)-Prion Peptide Complex. , 2019, Inorganic chemistry.

[16]  X. Qu,et al.  Chirality-Selected Chemical Modulation of Amyloid Aggregation. , 2019, Journal of the American Chemical Society.

[17]  Y. Matsuyama,et al.  A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques , 2019, Nature Biomedical Engineering.

[18]  Mathias Jucker,et al.  Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases , 2018, Nature Neuroscience.

[19]  C. Soto,et al.  Inhibition of protein misfolding and aggregation by natural phenolic compounds , 2018, Cellular and Molecular Life Sciences.

[20]  Yuhuan Sun,et al.  Redox‐Activated Near‐Infrared‐Responsive Polyoxometalates Used for Photothermal Treatment of Alzheimer's Disease , 2018, Advanced healthcare materials.

[21]  Yuhuan Sun,et al.  Rational design of a “sense and treat” system to target amyloid aggregates related to Alzheimer’s disease , 2018, Nano Research.

[22]  X. Qu,et al.  Stereochemistry and amyloid inhibition: Asymmetric triplex metallohelices enantioselectively bind to Aβ peptide , 2018, Science Advances.

[23]  Hailing Li,et al.  Nitration of Tyrosine Residue Y10 of Aβ1-42 Significantly Inhibits Its Aggregation and Cytotoxicity. , 2017, Chemical research in toxicology.

[24]  A. Ramamoorthy,et al.  An Iridium(III) Complex as a Photoactivatable Tool for Oxidation of Amyloidogenic Peptides with Subsequent Modulation of Peptide Aggregation. , 2017, Chemistry.

[25]  J. Collinge.  Mammalian prions and their wider relevance in neurodegenerative diseases , 2016, Nature.

[26]  X. Qu,et al.  Ceria/POMs hybrid nanoparticles as a mimicking metallopeptidase for treatment of neurotoxicity of amyloid-β peptide. , 2016, Biomaterials.

[27]  X. Qu,et al.  Polyoxometalate-based nanozyme: Design of a multifunctional enzyme for multi-faceted treatment of Alzheimer’s disease , 2016, Nano Research.

[28]  Xuesong Wang,et al.  Methionine oxidation of amyloid peptides by peroxovanadium complexes: inhibition of fibril formation through a distinct mechanism. , 2015, Metallomics : integrated biometal science.

[29]  D. M. Fernandes,et al.  Carbon Nanomaterial–Phosphomolybdate Composites for Oxidative Electrocatalysis , 2015 .

[30]  Hanjun Sun,et al.  Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer’s disease , 2014, Nature Communications.

[31]  X. Qu,et al.  Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease. , 2013, Small.

[32]  Jia Xu,et al.  Interaction of the human prion protein PrP106-126 with metal complexes: potential therapeutic agents against prion disease. , 2010, Chemistry.

[33]  Chun Wu,et al.  Oligomers of the prion protein fragment 106-126 are likely assembled from beta-hairpins in solution, and methionine oxidation inhibits assembly without altering the peptide's monomeric conformation. , 2010, Journal of the American Chemical Society.

[34]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[35]  R. Pogni,et al.  Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies. , 2005, Journal of the American Chemical Society.

[36]  C. Schöneich.  Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. , 2005, Biochimica et biophysica acta.

[37]  J. Brewer,et al.  Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation , 2004 .

[38]  D. Pogocki,et al.  Free radical reactions of methionine in peptides: mechanisms relevant to beta-amyloid oxidation and Alzheimer's disease. , 2003, Journal of the American Chemical Society.

[39]  J. Poblet,et al.  Electronic Properties of Polyoxometalates: A DFT Study of α/β-[XM12O40]n- Relative Stability (M = W, Mo and X a Main Group Element) , 2001 .

[40]  J. Poblet,et al.  Electronic and Magnetic Properties of α-Keggin Anions: A DFT Study of [XM12O40]n-, (M = W, Mo; X = AlIII, SiIV, PV, FeIII, CoII, CoIII ) and [SiM11VO40]m- (M = Mo and W) , 2001 .

[41]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[42]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[43]  J. Burdett,et al.  Band Gap and Stability of Solids , 1988 .

[44]  P. Domaille.  The 1- and 2-dimensional tungsten-183 and vanadium-51 NMR characterization of isopolymetalates and heteropolymetalates , 1984 .

[45]  W. K. Musker,et al.  An investigation of mesocyclic and acyclic dithioether cation radicals and dications , 1978 .

[46]  G. Tsigdinos,et al.  Molybdovanadophosphoric acids and their salts. I. Investigation of methods of preparation and characterization , 1968 .